METTL14 and urinary bladder carcinoma: In contrast, METTL14 (Gu et al., 2019; Guimarães Teixeira et al., 2022), WTAP (Liu et al., 2021a), YTHDC1, YTHDF3, ZC3H13 (Deng et al., 2022) were reduced in bladder cancer samples.